Healthcare Services Group Inc (HCSG)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $1.68B
Last updated: Nov 17, 2026 at 11:05 AM ET
Healthcare Services Group Inc (HCSG) Financials: Revenue, Profit and Cash Flow
Healthcare Services Group reported revenue of $1.84B for the fiscal year ended Dec 31, 2025, up 7.1% from the year before. That year, net income was $59.06M with a net margin of 3.2%, operating cash flow was $144.97M and free cash flow was $139.15M. The quarter ended Sep 30, 2026 had revenue of $479.60M and net income of $24.88M.
Revenue and Margins
The operating margin was 2.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.56B, a compound annual rate of 1.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.84B | +7.1% | 13.0% | 2.6% | 3.2% |
| Dec 2024 | $1.72B | +2.7% | 13.3% | 2.6% | 2.3% |
| Dec 2023 | $1.67B | -1.1% | 12.8% | 2.9% | 2.3% |
| Dec 2022 | $1.69B | +2.9% | 11.4% | 3.1% | 2.0% |
| Dec 2021 | $1.64B | -6.7% | 14.0% | 3.5% | 3.0% |
| Dec 2020 | $1.76B | -4.4% | 15.2% | 6.7% | 5.6% |
| Dec 2019 | $1.84B | -8.1% | 12.4% | 4.2% | 3.5% |
| Dec 2018 | $2.00B | +7.6% | 11.7% | 4.9% | 4.2% |
| Dec 2017 | $1.86B | +19.1% | 13.5% | 6.7% | 4.7% |
| Dec 2016 | $1.56B | N/A | 14.3% | 7.5% | 5.0% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 49.6% from the year before. In the quarter ended Sep 2026, net income fell 42.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.84B | $1.72B | $1.67B | $1.69B | $1.64B | $1.76B | $1.84B | $2.00B | $1.86B | $1.56B |
| Cost of revenue | $1.60B | $1.49B | $1.46B | $1.50B | $1.41B | $1.49B | $1.61B | $1.77B | $1.61B | $1.34B |
| Gross profit | $239.41M | $228.09M | $214.75M | $193.31M | $230.57M | $267.99M | $227.90M | $234.44M | $250.62M | $223.17M |
| Operating income | $48.54M | $45.03M | $47.97M | $52.97M | $57.46M | $117.21M | $77.88M | $97.84M | $123.88M | $117.75M |
| Net income | $59.06M | $39.47M | $38.39M | $34.24M | $48.54M | $98.68M | $64.58M | $83.52M | $88.23M | $77.40M |
| EBITDA | $65.61M | $61.12M | $64.46M | $70.50M | $74.40M | $133.30M | $93.25M | $108.48M | $134.07M | $126.97M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $479.60M | $470.81M | $462.77M | $466.68M | $464.34M | $458.49M | $447.66M | $437.81M | $428.15M | $426.29M | $423.43M | $423.84M |
| Gross profit | $80.39M | $74.79M | $75.83M | $72.07M | $96.41M | $2.96M | $67.97M | $58.60M | $63.42M | $41.55M | $64.52M | $74.72M |
| Operating income | $31.94M | $22.21M | $33.84M | $25.88M | $45.86M | -$46.20M | $23.00M | $13.78M | $16.53M | -$2.89M | $17.61M | $28.47M |
| Net income | $24.88M | $22.70M | $26.06M | $31.24M | $42.95M | -$32.37M | $17.23M | $11.92M | $14.03M | -$1.79M | $15.31M | $23.51M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $5.36M by $119.83M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $794.25M | $802.77M | $790.65M | $720.84M | $777.53M | $785.03M | $722.59M | $692.60M | $676.00M | $528.45M |
| Current assets | $576.41M | $556.65M | $571.70M | $508.63M | $546.38M | $572.40M | $515.73M | $508.14M | $527.41M | $414.62M |
| Cash and equivalents | $125.19M | $56.78M | $54.33M | $26.28M | $70.79M | $139.33M | $27.33M | $26.02M | $9.56M | $23.85M |
| Total liabilities | $284.04M | $302.85M | $334.04M | $302.56M | $324.85M | $304.57M | $262.29M | $251.82M | $276.05M | $189.60M |
| Short-term debt | $5.36M | $8.40M | $25.00M | $25.00M | $0 | $5.30M | $15.18M | $30.00M | $35.38M | N/A |
| Shareholder equity | $510.21M | $499.93M | $456.62M | $418.28M | $452.68M | $480.46M | $460.31M | $440.78M | $399.95M | $338.84M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $850.40M | $820.86M | $814.85M | $807.78M | $804.30M | $802.20M | $822.96M | $815.47M | $805.84M | $799.70M | $803.88M | $803.18M |
| Total liabilities | $318.95M | $302.01M | $301.08M | $297.57M | $308.30M | $325.16M | $308.76M | $315.55M | $317.09M | $328.28M | $329.30M | $346.57M |
| Cash and equivalents | $134.60M | $123.41M | $136.17M | $161.12M | $124.39M | $82.82M | $64.32M | $85.24M | $27.05M | $26.43M | $29.29M | $54.33M |
| Shareholder equity | $531.45M | $518.84M | $513.77M | $510.21M | $496.00M | $477.04M | $514.20M | $499.93M | $488.75M | $471.42M | $474.58M | $456.62M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 96.0% of operating cash flow. Share repurchases came to 44.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $144.97M | $30.80M | $43.50M | -$8.17M | $37.11M | $217.21M | $93.58M | $80.03M | $7.63M | $41.40M |
| Capital expenditures | $5.82M | $6.34M | $5.41M | $5.21M | $5.69M | $4.34M | $4.37M | $4.94M | $5.40M | $5.44M |
| Free cash flow | $139.15M | $24.47M | $38.09M | -$13.38M | $31.42M | $212.87M | $89.21M | $75.09M | $2.23M | $35.96M |
| Dividends paid | N/A | $0 | $15.98M | $63.37M | $62.23M | $60.70M | $58.95M | $57.20M | $55.24M | $53.34M |
| Share repurchases | $61.59M | $5.02M | $11.28M | $1.07M | $22.95M | $675.00K | $587.00K | $284.00K | N/A | N/A |
| Investing cash flow | -$11.00M | $6.05M | -$3.29M | $2.58M | -$22.99M | -$36.84M | -$16.46M | -$9.59M | -$14.97M | -$6.45M |
| Financing cash flow | -$63.33M | -$31.05M | -$12.15M | -$38.93M | -$82.65M | -$68.37M | -$75.82M | -$53.98M | -$6.96M | -$44.28M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $30.17M | $21.87M | $43.73M | $17.39M | $71.29M | $28.79M | $27.50M | $36.20M | $4.31M | $16.32M | -$26.03M | $49.45M |
| Capital expenditures | $2.07M | $1.63M | $1.40M | $1.38M | $1.34M | $1.36M | $1.74M | $1.43M | $1.40M | $1.31M | $2.20M | $1.43M |
| Free cash flow | $28.10M | $20.24M | $42.33M | $16.01M | $69.96M | $27.43M | $25.76M | $34.78M | $2.91M | $15.01M | -$28.23M | $48.01M |
Frequently Asked Questions About HCSG
What is Healthcare Services Group's annual revenue?
Healthcare Services Group reported revenue of $1.84B for the fiscal year ended Dec 31, 2025.
How fast is Healthcare Services Group's revenue growing?
Revenue was up 7.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.8%.
Is Healthcare Services Group profitable?
Yes. Healthcare Services Group reported net income of $59.06M for the fiscal year ended Dec 31, 2025, with a net margin of 3.2%.
How much free cash flow does HCSG generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $144.97M minus capital expenditures of $5.82M produced free cash flow of $139.15M.
How much debt does Healthcare Services Group have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $5.36M and cash and equivalents of $125.19M.
HCSG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors